Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $26.90, giving the company a market capitalization of 153.7B. It carries a P/E multiple of 19.95 and pays a dividend yield of 6.4%.
As of 2026-03-07, Pfizer(PFE) stock has fluctuated between $26.23 and $27.13. The current price stands at $26.90, placing the stock +2.6% above today's low and -0.8% off the high.
Pfizer(PFE) shares are trading with a volume of 53.18M, against a daily average of 37.97M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 70% Off TipRanks Premium Unlock hedge fund-lev...
Pfizer (NYSE:PFE) and Astellas report positive Phase 3 results for PADCEV plus Keytruda in muscle invasive bladder cancer. The combination is linked to lower r...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a new Phase 1 study in China titled “A Phase 1, Open-label...
Analyst ratings
55%
of 29 ratingsMore PFE News
China's National Medical Products Administration has approved Pfizer Inc.’s (NYSE:PFE) ecnoglutide injection for chronic weight management in adults with overwe...
Pfizer (PFE) has received regulatory approval in China for its GLP-1 treatment Xianweiying for long-term weight management in overweight and obese adults. The a...
Key Points Teva Pharmaceutical is a bit of a turnaround story, as the company continues a major business overhaul. This competitor, with a huge 6.3% yield, ha...
It’s been a lackluster year so far for U.S. equities. Year-to-date, the benchmark S&P 500 is slightly in the red, weighed down primarily by a selloff in mega-ca...
In late February 2026, Pfizer and Astellas reported that PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscl...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 1 study called “A PHASE 1, OPEN-LABEL, SINGLE-DOSE,...
Advertisement What Pfizer’s Recent Share Performance Signals for Investors With no single headline event driving the move, Pfizer (PFE) has quietly posted pos...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.